U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Form 10-QSB
Quarterly Report Under
the Securities Exchange Act of 1934
For Quarter Ended: August 31, 1996
Commission File Number: 0-26920
USAsurance Group, Inc.
(Exact name of small business issuer as specified in its charter)
Colorado
(State or other jurisdiction of incorporation or organization)
84-1298212
(IRS Employer Identification No.)
7345 E. Peakview Ave.
Englewood, Colorado
(Address of principal executive offices)
80111
(Zip Code)
(303) 689-0123
(Issuer's Telephone Number)
(Former name, former address and former fiscal year, if changed
since last report)
Check whether the issuer (1) filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the past 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days:
Yes __X__ No _____.
The number of shares of the registrant's only class of common stock
issued and outstanding, as of August 31, 1996, was 1,566,000
shares.
<PAGE>
PART I
ITEM 1. FINANCIAL STATEMENTS.
The unaudited financial statements for the three month period
ended August 31, 1996, are attached hereto.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read in conjunction with
the Financial Statements and notes thereto included herein.
GENERAL
USAsurance Group, Inc. (the "Company"), is a company
incorporated pursuant to the laws of the State of Colorado on
January 15, 1991, for the purpose of engaging as an insurance
brokerage company. The Company did not undertake any business
activities relevant thereto and in June 1995, the Company's Board
of Directors elected to change the Company's principal business
activities to the viatical settlement industry. Viatical
settlements are made to persons who are terminally ill and who want
to sell their life insurance to obtain the benefit of the money
provided by the settlement during the remainder of their life.
RESULTS FROM OPERATIONS
Comparison of Results of Operations for the three month period
ended August 31, 1996 and three month period ended August 31, 1995
The Company's revenues for the three month period ended August
31, 1996 were $5,059 compared to $2,438 for the three month period
ended August 31, 1995. The increase in revenues was a result of
the maturity of policies during the three months ended August 31,
1996. Total revenues increased $2,621 or 108% from $2,438 to
$5,059. In the three month period ended August 31, 1996, expenses
increased $15,313, or 573% from $2,671 to $17,984 in August 31,
1995. This increase was due to costs associated with increased
general and administrative expenses, including legal and accounting
expenses.
The Company's net operating income increased from ($233) to
($12,925), primarily due to the increase of operating activities.
Interest expense increased by approximately $2,819. The
increase resulted primarily from notes payable issued to the
Company's lenders, to fund purchases of policies.
Since June 1995 the Company has purchased, for its own
account, 12 different insurance policies with a face value of
$628,294 from individuals, for an aggregate purchase price of
2
<PAGE>
$565,795. Three of these policies in the amount of $183,100 have
matured and the proceeds from these policies have been paid to the
Company. The Company recognizes income (earned discount) on each
purchased policy by accruing, over the period between the
acquisition date of the policy and the Company's estimated date of
collection of the face value of the policy (the accrual period),
the difference (the unearned discount) between (a) the death
benefit payable (face value under the policy less the amount of
fees, if any, payable to a referral source upon collection of the
face value; and (b) the carrying value of the policy. The
carrying value of each policy is reflected on the Company's balance
sheet under "purchased life insurance policies" and consists of the
purchase price, other capitalized cost and the earned discount on
the policy accrued to the balance sheet date. The Company
capitalizes as incurred the following costs of a purchased policy:
(i) the purchased price paid for the policy; (ii) policy
premiums, if any, paid by the Company; (iii) amounts, if any,
paid to referral sources upon acquisition of the policy; and (iv)
amounts paid to the Company retained physicians or other medical
consultants who estimated the insured's life expectancy. The
carrying value of a policy change over time and is adjusted
quarterly to reflect the earned discounts accrued on the policy,
amounts paid for any additional future increases in coverage, any
additional premium payments and any premium refunds if the policy
becomes covered by premium waiver provisions. The length of the
accrual period is determined by the Company based upon its estimate
of the date on which it will collect the face value of the policy.
Such date is based upon the Company's estimate of the life
expectancy of the insured, after review of the medical records of
the insured by our medical consultants, and also takes into account
the historical accuracy of the life expectancies estimated by the
Company's consultants and the typical period (collection period)
between the date of the insured's death and the date on which the
Company collects the face value of the policy.
The unearned discount is accrued over the accrual period using
the straight line method. Under the straight line method, the
unearned discount is earned evenly throughout the accrual period
and the unearned discount will be fully accrued as earned discount
by the end of the accrual period.
The weighted average original Accrual period of the Company's
portfolio of policies comprising "purchased life insurance
policies" and "matured policies receivable" as of August 31, 1996
was 9.0 months. At that date, 4.5 months of the accrual period had
elapsed, leaving a weighted average remaining accrual period at the
end of the period of 4.5 months. The average accrual period will
change as the composition of policies comprising the Companys
portfolio changes. To the extent the Company purchases policies
insuring lives of individuals with longer life expectancies, the
average accrual period will become longer. The Company has a
relatively limited operating history and as it accumulates more
3
<PAGE>
experience and data, it may need to revise the accrual periods for
existing and newly acquired policies to reflect more accurately
such experience and data. In addition, the Company has been using
several consultants to estimate life expectancies of insureds
afflicted with AIDS. accrual periods may also be revised if (i)
such consultants become more or less accurate in their estimates of
life expectancies of insureds; (ii) the Company uses additional or
different consultants who produce different levels of accuracy ; or
(iii) the Company purchases more non-Aids policies or policies
insuring the lives of individuals with longer life expectancies,
both of which may result in different levels of life expectancy
accuracy.
Any change in accrual periods will not cause a restatement of
earned discounts in prior periods but will impact earned discounts
in the current and future periods on both policies then owned by
the Company (by either accelerating or decelerating the recognition
of remaining unearned discount) and policies thereafter acquired by
the Company. The Company cannot predict how any accrual period
will change, if at all, in the future.
LIQUIDITY AND CAPITAL RESOURCES
The Company's primary need for capital has been for the
funding of policy purchases. Since commencement of its business
operations described herein in June 1995, the Company has primarily
utilized the proceeds which it derived from its private offering to
implement its business plan of purchasing insurance policies. The
Company intends to attempt to continue to implement its business
plan during the next 12 months. While it is perceived by
management that there are numerous potential sellers in the
viatical market, management believes that the Company may be
limited in the number of insurance policies the Company may acquire
because of the Company's present limited financial resources. In
response thereto, management has undertaken various discussions
with investment bankers and venture capitalists in order to arrange
to provide the Company with additional financial resources. The
Company expects to raise additional capital by a private placement.
It is anticipated the offering will begin in the next fiscal
quarter and will involve the sale of up to 2,000,000 shares of the
Company's common stock at $5.00 a share.
To the extent the Company is successful in obtaining
additional capital from the offering, of which there can be no
assurance, such capital will be used to further the present
activity of the Company and to expand the Company's business into
other insurance related activities including but not limited to,
the purchase of an unrelated insurance company. As of the date of
this report, management has had informal discussions with potential
acquisition candidates, but the Company has no definitive agreement
with any other entity wherein the Company has agreed to acquire
such company. In the event the Company is unable to obtain
4
<PAGE>
additional capital, management intends to continue to fund the
Company's acquisition of insurance policies through the proceeds
derived from operations, if any. There can be no assurances that
the Company will continue to generate profits from its current
operations, or if such profits are generated, that the Company will
be able to significantly increase the number of policies it
purchases. If possible, the Company may explore the possibility of
obtaining loans from established financial institutions. However,
while the Company has had informal discussions with various
financial institutions to obtain loans, as of the date hereof,
there is no agreement between the Company and any financial entity
wherein the Company will obtain any additional funding, either
equity or debt.
The Company's cash requirements have been and will continue to
be significant in order to finance its policy purchases. As a
result of accruing income on each purchased policy prior to
collecting the face value, the amount of earned discount recognized
is not related to the collection of cash by the Company on
policies. Net cash flows provided by operating activities has
decreased by $76,683. This was due to an increase in policies
purchased.
Of the policies purchased by the Company since June 1995, all
of these policies have been purchased from individuals diagnosed
with Human Immunodeficiency Virus (HIV). In deference to new
treatments involving combinations of various drugs for treating HIV
positive patients, the Company has temporarily slowed down its
activities relating to the purchasing of policies which insure
people afflicted with AIDS and HIV will not take an aggressive
approach to such acquisitions until additional information can be
obtained and analyzed relating to the effect these new treatments.
At the present, management is of the opinion that insufficient
information is available to allow the Company to make decisions on
accrual periods or in the methodology for income recognition. The
Company is continuing to analyze available data regarding new
treatments and cannot, as of the date of this report, predict what
impact this situation will have on its business, prospects, results
of operations or financial position. Additionally, the Company has
not determined the implication of these recent developments on the
Company's strategic direction. Until management is satisfied as to
the future treatment of AIDS, the Company will not utilize any
additional debt capital to purchase insurance policies from
individuals diagnosed as HIV positive or with AIDS. However, the
Company will consider purchasing insurance policies of persons
afflicted with other terminal diseases.
It is not anticipated that the Company will expend any of its
present financial resources on the purchase of any significant
equipment in the future, nor is it anticipated that the number of
employees of the Company will increase to any significant degree in
the future.
5
<PAGE>
Inflation has not had and is not expected to have a
significant impact on the Company's financial position or operating
results.
The Company's common stock shares are currently traded on the
NASDAQ over the counter Bulletin Board using the trading symbol
UASG.
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS - None
ITEM 2. CHANGES IN SECURITIES - NONE
ITEM 3. DEFAULTS UPON SENIOR SECURITIES - NONE
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS -
NONE.
ITEM 5. OTHER INFORMATION - NONE.
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
EX-27 Financial Data Schedule
(b) Reports on Form 8-K - None.
6
<PAGE>
<TABLE>
USAsurance Group, Inc.
Balance Sheet
<CAPTION>
Unaudited Audited
August May
31, 1996 31, 1996
________ ________
<S> <C> <C>
ASSETS
Current Assets:
Cash $47,677 $124,540
Other Receivables 0 12,000
Purchased Life Insurance Policies 438,944 0
Deposits With Escrow Company 38,476 389,405
________ ________
Total Current Assets 525,097 525,945
________ ________
Equipment (net of depreciation) 2295 2,430
________ ________
Other Assets:
Deffered Tax Asset 6,100 6,100
Prepaid Income Taxes 2,000 0
________ ________
Total Other Assets 8,100 6,100
________ ________
TOTAL ASSETS $535,492 $534,475
LIABILITIES AND SHAREHOLDERS' EQUITY
LIABILITIES
Current Liabilities:
Accounts Payable $6,780 $1,534
Deferred Tax Liability 10,900 10,900
Interest Payable 12,274 9,205
________ ________
Total Current Liabilities 29,954 21,639
________ ________
Long-Term Debt - Related Party 75,000 75,000
Long-Term Debt - Other 100,340 100,340
________ ________
Total Long-Term Debt 175,340 175,340
________ ________
7
<PAGE>
TOTAL LIABILITIES 205,294 196,979
________ ________
SHAREHOLDERS' EQUITY
Common Stock, $.0001 Par Value
Authorized 900,000,000 Shares;
Issued And Outstanding 1,566,000 Shares 157 157
Capital Paid In Excess Of
Par Value Of Common Stock 373,341 364,991
Preferred Stock, $.01 Par Value, Non Voting
Authorized 1,000,000 Shares;
Issued And Outstanding -0- Shares 0 0
Retained Earnings (Deficit) (43,300) (27,652)
________ ________
TOTAL SHAREHOLDERS' EQUITY 330,198 337,496
________ ________
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $535,492 $534,475
<FN>
The Accompanying Notes Are An Integral Part Of These
Unaudited Financial Statements.
</TABLE>
8
<PAGE>
<TABLE>
USAsurance Group, Inc.
Statement Of Operations
<CAPTION>
Unaudited Unaudited
3 Month 3 Month
Period EndPeriod Ended
August August
31, 1996 31, 1995
________ ________
<S> <C> <C>
Income:
Earned Discount On Life Insurance Policies $5,059 $2,438
Interest 0 0
________ ________
Total Income 5,059 2,438
________ ________
Expenses:
Contract Labor 8,250 0
Depreciation 135 0
Legal And Accounting 9,200 0
Office 174 171
Professional Dues 0 2,500
Rent 100
Telephone 125 0
Total 17,984 2,671
________ ________
Net Profit From Operations (12,925) (233)
________ ________
Other Income (Expense)
Interest Income 96 25
Interest Expense (2,819) 0
________ ________
Total Other Income (Expense) (2,723) 25
________ ________
Net Profit ($15,648) ($208)
Net Profit Per
Common Share ($0.01) ($0.00)
Weighted Average Common Shares
Outstanding 1,566,000 1,566,000
<FN>
The Accompanying Notes Are An Integral Part Of These
Unaudited Financial Statements.
</TABLE>
9
<PAGE>
<TABLE>
USAsurance Group, Inc.
Statement Of Cash Flows
<CAPTION>
Unaudited Unaudited
3 Month 3 Month
Period EndPeriod Ended
August August
31, 1996 31, 1995
________ ________
<S> <C> <C>
Net (Loss) ($15,648) ($208)
Adjustments To Reconcile Net Loss To Net Cash
Used In Operating Activities:
Depreciation 135 0
Contributed Services And Rent 8,350 0
Changes In Operating Assets And Liabilities:
(Increase) Decrease In Receivable 12,000 (25,025)
(Increase) In Purchased Life Insurance Polic (49,539) (326,899)
(Increase) In Deposits With Life Insurance C (38,476) 0
(Increase) In Prepaid Expenses (2,000) 0
Increase In Accounts Payable 5,246
Increase In Interest Payable 3,069 0
________ ________
Net Flows From Operations (76,863) (352,132)
________ ________
Cash Flows From Investing Activities 0 0
________ ________
Net Cash Flows From Investing 0 0
________ ________
Cash Flows From Financing Activities:
Issuance Of Common Stock 0 330,000
Funds Received From Loans 0 58,500
Advances From Related Parties 0 75,000
Payments Made On Loans 0 0
________ ________
Cash Flows From Financing 0 463,500
________ ________
Net Increase In Cash (76,863) 111,368
Cash At Beginning Of Period 124,540 0
________ ________
10
<PAGE>
Cash At End Of Period $47,677 $111,368
Summary Of Non-Cash Investing And Financing Activities:
Inventory Purchased By Related Party as
Loan To Related Party $0 $42,340
<FN>
The Accompanying Notes Are An Integral Part Of These
Unaudited Financial Statements.
</TABLE>
11
<PAGE>
USAsurance Group, Inc.
Notes to Unaudited Financial Statements
For the Three Month Period Ended August 31, 1996
Note 1 - Unaudited Financial Information
The unaudited financial information included for the three month
interim periods ended August 31, 1996 and 1995 were taken from the
books and records without audit. However, such information
reflects all adjustments (consisting only of normal recurring
adjustments, which are of the opinion of management, necessary to
reflect properly the results of interim periods presented). The
results of operations for the three month period ended August 31,
1996 are not necessarily indicative of the results expected for the
fiscal year ended May 31, 1997.
Note 2 - Type of Life Insurance Policies and Collection of Proceeds
The Company has purchased both group and individual policies that
include term, whole life, and universal life insurance from various
individuals that have life expectancies of 12 months or less. Upon
the maturity of the policies the Company will receive a cashiers
check for the face amount of the policy made out to the Company
within 30 days.
Note 3 - Purchased Life Insurance Policies
The Company recognizes income (earned discount) on each purchased
policy by accruing, over the period between the acquisition date of
the policy and the Company's estimated date of collection of the
face value of the policy (the Accrual Period), the difference (the
unearned discount) between, (a) the death benefit payable (face
value) under the policy less the amount of fees, if any, payable to
a referral source upon collection of the face value, and (b) the
carrying value of the policy. The carrying value of each policy is
reflected on the Company's balance sheet under "purchased life
insurance policies" and consists of the purchase price, other
capitalized costs, and the earned discount on the policy accrued to
the balance sheet date. The Company capitalizes as incurred the
following costs of a purchased policy: (i) the purchase price paid
for the policy, (ii) policy premiums, if any, paid by the Company,
(iii) amounts, if any, paid to referral sources upon acquisition of
the policy, and (iv) amounts paid to Company retained physicians or
other medical consultants who estimated the insured's life
expectancy. The carrying value of a policy will change over time,
and is adjusted quarterly to reflect the earned discounts accrued
on the policy, amounts paid for any additional future increases in
coverage, any additional premium payments and any premium refunds
if the policy becomes covered by premium waiver provisions. The
length of the Accrual Period is determined by the Company based
upon its estimate of the date on which it will collect the face
value of the policy. Such estimate is based upon the Company's
12
<PAGE>
USAsurance Group, Inc.
Notes to Unaudited Financial Statements
For the Three Month Period Ended August 31, 1996
Note 3 - Continued
estimate of the life expectancy of the insured, after review of the
medical records of the insured by one or more Consultants, and also
take into account the historical accuracy of the life expectancies
estimated by the Company's Consultants and the typical period
(collection period) between the date of the insured death's and the
date on which the Company collects the face value of the policy.
The unearned discount is accrued over the accrual period using the
straight line method, regardless of when the Company collects the
face value. Under the straight line method, the unearned discount
is earned evenly throughout the accrual period and the unearned
discount will be fully accrued as earned discount by the end of the
accrual period.
Differences will arise between the timing of estimated and actual
collections. The Company recalculates the accrual periods on a
quarterly basis, using actual collection experience and, if
necessary, adjusts prospectively the period over which income is
recognized.
Purchased life insurance policies consist of the following as of
August 31, 1996:
<TABLE>
<S> <C>
Capitalized costs of purchased
life insurance policies $404,806
Earned discount 34,138
________
Purchased life insurance policies $438,944
</TABLE>
Purchased life insurance policies included in the above table for
which the discount has been fully earned, but for which the Company
has not yet received notification of the insured's death, consist
of the following at August 31, 1996:
<TABLE>
<S> <C>
Capitalized costs of purchased
life insurance policies $283,566
Earned discount 14,434
________
Included in purchased
life insurance policies $298,0800
</TABLE>
13
<PAGE>
USAsurance Group, Inc.
Notes to Unaudited Financial Statements
For the Three Month Period Ended August 31, 1996
Note 4 - Unearned Discount
As of August 31, 1996 there were $10,502 in unearned discounts.
All policies at August 31, 1996 are expected to mature in 12 months
or less.
14
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 12 of the
Securities and Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned,thereunto
duly authorized.
USAsurance Group, Inc.
(Registrant)
Dated: October 21, 1996
By: s/Thomas J. Chase
Thomas J. Chase
President and
Chief Financial Officer
15
<PAGE>
USAsurance Group, Inc.
EXHIBIT INDEX TO QUARTERLY REPORT ON FORM 10-QSB
FOR THE QUARTER ENDED AUGUST 31, 1996
EXHIBITS
EX-27 Financial Data Schedule
16
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED FINANCIAL STATEMENTS FILED WITH FORM 10-QSB FOR THE THREE MONTH PERIOD
ENDED AUGUST 31, 1996, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> MAY-31-1996
<PERIOD-END> AUG-31-1996
<CASH> 47,677
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 477,420
<CURRENT-ASSETS> 525,097
<PP&E> 2,295
<DEPRECIATION> 0
<TOTAL-ASSETS> 535,492
<CURRENT-LIABILITIES> 29,954
<BONDS> 0
0
0
<COMMON> 157
<OTHER-SE> 340,041
<TOTAL-LIABILITY-AND-EQUITY> 535,492
<SALES> 5,059
<TOTAL-REVENUES> 5,155
<CGS> 0
<TOTAL-COSTS> 17,984
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 2,819
<INCOME-PRETAX> (15,648)
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (15,648)
<EPS-PRIMARY> 0
<EPS-DILUTED> 0
</TABLE>
